Towards the pharmacotherapy of hairy cell leukaemia

Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma

1994 • 747 citations

Leukemic Reticuloendotheliosis

1958 • 542 citations

Lasting Remissions in Hairy-Cell Leukemia Induced by a Single Infusion of 2-Chlorodeoxyadenosine

1990 • 521 citations

Efficacy of the Anti-CD22 Recombinant Immunotoxin BL22 in Chemotherapy-Resistant Hairy-Cell Leukemia

2001 • 514 citations

Long-Term Follow-Up of Patients With Hairy Cell Leukemia After Cladribine Treatment

1998 • 318 citations

Extended Follow-Up of Patients With Hairy Cell Leukemia After Treatment With Cladribine

2003 • 273 citations

Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study.

1995 • 268 citations

Treatment of hairy cell leukemia with recombinant alpha-interferon

1986 • 267 citations

Remissions in Hairy-Cell Leukemia with Pentostatin (2′-Deoxycoformycin)

1987 • 265 citations

2-chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia

1994 • 211 citations

Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin.

2000 • 170 citations

Responses in Refractory Hairy Cell Leukemia to a Recombinant Immunotoxin

1999 • 169 citations

Response to splenectomy in 65 patients with hairy cell leukemia: an evaluation of spleen weight and bone marrow involvement

1983 • 164 citations

Rituximab in relapsed or refractory hairy cell leukemia

2003 • 162 citations

Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia

2003 • 158 citations

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients.

1998 • 157 citations

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA)

1992 • 154 citations

On the bioavailability of oral and subcutaneous 2-chloro-2'-deoxyadenosine in humans: alternative routes of administration.

1992 • 129 citations

Newer Purine Analogues for the Treatment of Hairy-Cell Leukemia

1994 • 125 citations

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA)

1992 • 121 citations

Second Malignancies in Patients With Hairy Cell Leukemia in British Columbia: A 20-Year Experience

1998 • 121 citations

Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2'-deoxyadenosine (CdA): relation to opportunistic infections

1992 • 120 citations

Second cancer risk in hairy cell leukemia: analysis of 350 patients.

1997 • 117 citations

Rituximab, a chimaeric anti‐CD20 monoclonal antibody, in the treatment of hairy cell leukaemia

2001 • 111 citations

Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients

2003 • 107 citations

Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia.

1995 • 104 citations

Relapse of hairy cell leukemia after 2-chlorodeoxyadenosine: long-term follow-up of the Northwestern University experience

1996 • 103 citations

Incidence of response and long-term follow-up in patients with hairy cell leukemia treated with recombinant interferon alfa-2a [see comments]

1990 • 98 citations

Long‐term follow‐up of patients with hairy cell leukaemia after treatment with pentostatin or cladribine

1999 • 92 citations

Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2'-deoxyadenosine (CdA): relation to opportunistic infections

1992 • 91 citations

Long-term follow-up of patients with hairy cell leukemia after treatment with 2'-deoxycoformycin

1994 • 89 citations

Second malignancies in hairy cell leukemia

1985 • 78 citations

Interferon in the treatment of hairy-cell leukemia

2003 • 75 citations

Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemia

1993 • 67 citations

Mechanism of interferon action in hairy cell leukemia: a model of effective cancer biotherapy.

1992 • 63 citations

Clinical staging system for hairy-cell leukemia

1982 • 62 citations

Fludarabine therapy in hairy cell leukemia

1991 • 59 citations

Response of hairy cells to IFN-α involves induction of apoptosis through autocrine TNF-α and protection by adhesion

2002 • 57 citations

Deoxycoformycin in the treatment of patients with hairy cell leukemia

2000 • 56 citations

Hairy Cell Leukemia: A Five-Year Update on Seventy-One Patients

1983 • 55 citations

Risk of Second Cancer in Patients With Hairy Cell Leukemia: Long-Term Follow-Up

2002 • 55 citations

Long term outcome of patients with hairy cell leukemia treated with pentostatin

1999 • 54 citations

Hairy cell leukemia, a B-cell neoplasm that is particularly sensitive to the cytotoxic effect of anti-Tac(Fv)-PE38 (LMB-2).

2000 • 50 citations

Prolonged, continuous treatment of hairy cell leukemia patients with recombinant interferon-alpha 2a.

1991 • 49 citations

Response to interferon-alpha in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine.

1995 • 47 citations

Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey

1997 • 47 citations

Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications.

1999 • 42 citations

Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukaemia

1992 • 42 citations

Results of a Salvage Regimen in Refractory or Relapsed Non-Hodgkin's Lymphoma

1994 • 41 citations

Recombinant alpha-2b-interferon in therapy of previously untreated hairy cell leukemia: long-term follow-up results of study by Cancer and Leukemia Group B.

1995 • 35 citations

Weekly Administration of 2-Chlorodeoxyadenosine in Patients With Hairy-Cell Leukemia: A New Treatment Schedule Effective and Safer in Preventing Infectious Complications

1997 • 34 citations

Erythrokinetic Studies in Hairy‐Cell Leukaemia

1979 • 33 citations

Hairy Cell Leukaemia

1978 • 31 citations

Second Malignancy in Hairy Cell Leukaemia: No Evidence of Increased Incidence After Treatment with Interferon Alpha

1996 • 31 citations

Splenectomy vs. alpha interferon: A randomized study in patients with previously untreated hairy cell leukemia

1992 • 31 citations

Integrated genetic and physical map of the 1q31→q32.1 region, encompassing the RP12 locus, the F13B and HF1 genes, and the EEF1AL11 and RPL30 pseudogenes

1999 • 30 citations

Long-term outcome of hairy cell leukemia treated with 2-chlorodeoxyadenosine

1999 • 29 citations

Treatment of hairy-cell leukaemia with α-interferon (α-IFN)

1988 • 28 citations

Risk of Second Cancer in Patients With Hairy Cell Leukemia: Long-Term Follow-Up

2002 • 26 citations

Rapid restoration of natural killer activity following treatment with 2‐chlorodeoxyadenosine in 22 patients with hairy‐cell leukemia

1994 • 26 citations

Splenectomy and treatments of historical interest

2003 • 24 citations

Long-lasting decrease of CD4+/CD45RA+T cells in HCL patients after 2-chlorodeoxyadenosine (2-CdA) treatment

1999 • 22 citations

Immunobiological treatments of hairy-cell leukaemia

2003 • 21 citations

Peripheral blood and bone marrow changes following 2′-deoxycoformycin therapy in hairy cell leukemia. Results of 200 weeks' follow-up

1989 • 18 citations

Expression of the IFNα receptor in hairy cell leukaemia

1992 • 16 citations

Results in hairy‐cell leukemia patients treated with α‐interferon: Predictive prognostic factors

1992 • 9 citations

Cited By (0)

Loading...